Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer

British Journal of Surgery

Volumn 96, Issue 5, 2009, Pages 533-540

  Parente, F ^a   Marino, B ^a   DeVecchi, N ^b   Moretti, R ^b  

^a A MANZONI HOSPITAL   (Italy)

^b Local Health Care Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOCHEMISTRY; ITALY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; CANCER DIAGNOSIS; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; EDUCATIONAL STATUS; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; OCCULT BLOOD; PATIENT COMPLIANCE; PILOT STUDY; SEX RATIO; STATISTICS;

AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EDUCATIONAL STATUS; FEMALE; HUMANS; ITALY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PILOT PROJECTS; SEX DISTRIBUTION;

EID: 65249088412     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6568     Document Type: Article

References (36)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe 2006. Ann Oncol 2007; 18: 581-592. (Pubitemid 46359643)
2. Grande E, Inghelmann R, Francisci S, Verdecchia A, Micheli A, Baili P et al. Regional estimates of colorectal cancer burden in Italy. Tumori 2007; 93: 352-359. (Pubitemid 47403450)
3. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-796. (Pubitemid 47321601)
4. Ransohoff DF. Colon cancer screening in 2005: status and challenges. Gastroenterology 2005; 128: 1685-1695. (Pubitemid 40692560)
5. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl JMed 1993; 328: 1365-1371.
6. Kewenter J, Brevinge H, Engarås B, Haglind E, Ahrén C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by faecal occult blood testing. Results for 68 308 subjects. Scand J Gastroenterol 1994; 29: 468-473. (Pubitemid 24144518)
7. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471. (Pubitemid 26400241)
8. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477. (Pubitemid 26400242)
9. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103: 1541-1549.
10. West NJ, Poullis AP, Leicester RJ. The NHS Bowel Cancer Screening Programme - a realistic approach with additional benefits. Colorectal Dis 2007; 10: 708-714.
11. Castiglione G, Zappa M, Grazzini G. Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests. J Med Screen 2000; 7: 35-37. (Pubitemid 30305465)
12. Schlemper RJ, Kato Y, Stolte M. Diagnostic criteria for gastrointestinal carcinomas in Japan andWestern countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol 2000; 15(Suppl): G49-G57.
13. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, 5th edn. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804.
14. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985; 89: 328-336. (Pubitemid 15028589)
15. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995; 38: 1286-1295.
16. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006; 130: 1872-1885. (Pubitemid 43668826)
17. Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 2004; 13: 19-26. (Pubitemid 38328115)
18. Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007; 132: 2304-2312. (Pubitemid 46900821)
19. Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002; 50: 29-32. (Pubitemid 34028299)
20. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126: 1674-1680. (Pubitemid 38736331)
21. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004; 329: 133.
22. Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39: 846-851. (Pubitemid 39215455)
23. Denis B, Ruetsch M, Strentz P, Vogel JY, Guth F, Boyaval JM et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007; 56: 1579-1584. (Pubitemid 350033197)
24. Radaelli F, Meucci G, Sgroi G, Minoli G. Italian Association of Hospital Gastroenterologists (AIGO). Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol 2008; 103: 1122-1130.
25. Manfredi S, Piette C, Durand G, Plihon G, Mallard G, Bretagne JF. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance. Endoscopy 2008; 40: 422-427.
26. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C et al. Baseline findings of the Italian multicenter randomized controlled trial of 'Once-only sigmoidoscopy' - SCORE. J Natl Cancer Inst 2002; 94: 1763-1772.
27. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90.
28. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl JMed 2006; 355: 1863-1872. (Pubitemid 44664644)
29. Sant M, Aereleeid T, Berrino F, Bielska Lasota M, Carli PM, Fajvre J et al. EUROCARE-3: survival of cancer patients diagnosed 1990-1994 - results and commentary: EUROCARE Working Group. Ann Oncol 14(Suppl 5): V61-V118.
30. Read TE, Mutch MG, Chang BW, McNevin MS, Fleshman JW, Birnbaum EH et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J AmColl Surg 2002; 195: 33-40. (Pubitemid 34742997)
31. Bond JH. The place of fecal occult blood test in colorectal cancer screening in 2006: the US perspective. Am J Gastroenterol 2006; 101: 219-221.
32. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl JMed 2000; 343: 169-174. (Pubitemid 30489213)
33. Betés M, Muñoz-Navas MA, Duque JM, Angós R, Macías E, Súbtil JC et al. Use of colonoscopy as primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 2003; 98: 2648-2654. (Pubitemid 38020103)
34. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl JMed 2000; 343: 1603-1607. (Pubitemid 32162983)
35. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in average-risk population. N Engl JMed 2004; 351: 2704-2714. (Pubitemid 39665324)
36. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl JMed 2002; 346: 1781-1785. (Pubitemid 34586913)